Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Zhejiang University

Status: Unknown

Conditions: Cerebral Hemorrhage

Treatments: Drug: Low molecular weight heparin

Study type: Observational

Funder types: Other

Identifiers

NCT04450446

2020-315

Details and patient eligibility

About

The investigators retrospectively reviewed the electronic medical records of the patients with spontaneous cerebral hemorrhage and mechanical valves from 2015 to 2020 in the second affiliated hospital of Zhejiang university medical college. Medical documents and patient data were reviewed, including patient age, gender, type of mechanical heart valve, replacement time, replacement site, underlying disease, anticoagulant drugs at admission, type of cerebral hemorrhage, treatment mode, time without anticoagulant, length of stay, mortality, etc

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with spontaneous cerebral hemorrhage and mechanical valves

Exclusion criteria

• age<18y
• pregnant patients
• death in 24 hours without anticoagulant

Trial design

100 participants in 3 patient groups

cerebral hemorrhage

Treatment:

Drug: Low molecular weight heparin

thromboembolism

Treatment:

Drug: Low molecular weight heparin

no thromboembolism and cerebral hemorrhage

Treatment:

Drug: Low molecular weight heparin